Who owns Cellectar Biosciences, Inc.?
- Ticker: CLRB
- CUSIP Number: 15117f807
Tip: Access positions for across all investors
Analyze quarterly positions in Cellectar Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cellectar Biosciences stock
Who bought or sold Cellectar Biosciences, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 1.9M | $5.3M | 183% | Dec 2023 |
|
| ADAR1 Capital Management | 1.4M | $3.8M | 100% | Dec 2023 |
|
| Nantahala Capital Management | 1.4M | $3.7M | 100% | Dec 2023 |
|
| Worth Venture Partners | 694k | $1.9M | 149% | Dec 2023 |
|
| Rosalind Advisors | 622k | $2.5M | -69% | Mar 2024 |
|
| Vanguard Group | 483k | $1.3M | 175% | Dec 2023 |
|
| Citadel Advisors | 69k | $191k | 100% | Dec 2023 |
|
| Raymond James & Associates | 36k | $143k | 100% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 30k | $119k | 100% | Mar 2024 |
|
| LLBH Private Wealth Management | 23k | $64k | 100% | Dec 2023 |
|
| Commerce Bank N A | 12k | $33k | 0% | Dec 2023 |
|
| Simplex Trading | 3.7k | $14k | 100% | Mar 2024 |
|
| UBS Group | 1.2k | $3.3k | -4% | Dec 2023 |
|
| BFSG | 1.0k | $4.0k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 521.00 | $1.4k | -4% | Dec 2023 |
|
| Us Bancorp | 285.00 | $788.994000 | 0% | Dec 2023 |
|
| Wells Fargo & Company | 60.00 | $166.002000 | -15% | Dec 2023 |
|
| Harbour Investments | 40.00 | $111.000000 | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 20.00 | $55.000000 | 82% | Dec 2023 |
|
| AllSquare Wealth Management | 18.00 | $50.000400 | 0% | Dec 2023 |
|
| Bank of America Corporation | 16.00 | $44.000000 | 100% | Dec 2023 |
|